INTERNATIONAL SKATING UNION

Communication No. 1604
Revised due to a typing error on page 21, Article D.4 paragraph 2

ISU
ANTI-DOPINGPROCEDURES
to theISU ANTI-DOPING RULES
compiled in accordance withThe
World Anti-Doping
Code(This Communication replaces ISU Communication No. 1547, effective January 1, 2010)

TABLE OF CONTENTSINTRODUCTION .................................................................................................... 3
ATESTING ............................................................................................... 3
A.1 ............................................................................................................ ................ 3
A.2 .......................................................................................................... .................. 3
A.3 ........................................................................................................... ................. 3
A.4 ........................................................................................................... ................. 3
A.5 ........................................................................................................... ................. 3
A.6 ........................................................................................................... ................. 3
A.7
Analysis of Samples ................................................................................ 7
A.8
Analysis of B Samples ............................................................................ 8
BB.1
B.2
B.3
B.3.1
B.3.2
B.3.3
B.3.4
B.3.5
B.4
B.5
B.5.1
B.5.2
B.5.3
B.5.4
B.5.5
B.6

IN-COMPETITION TESTING ........……………….................... ...... 8................................................................................................... ............. 9
Supervision .............................................................................................. 9
Facilities, Equipment and Personnel ....................................................... 9
Doping Control Station .......................................................................... 9..............................................................………….......................... ......... 9
Sample collection equipment .................................................................. 9
Support personnel .................................................................................... 10
Accreditation of Doping Control personnel ............................................ 10
Selection and number of Skaters to be controlled ................................... 10
Skaters Selected for Post Competition Testing ....................................... 11................................................................................................................ 11
Figure Skating ........................................................................................ 11
Synchronized Skating .............................................................................. 12
Speed Skating .......................................................................................... 13
Short Track Speed Skating ...................................................................... 15
Notification and attendance at the Doping Control Station .................... 17

CC.1
C.2
C.3
C.3.1
C.3.2
C.3.3
C.3.4
C.3.5
C.4
C.5
C.6

OUT-OF-COMPETITION TESTING ................................................ 17................................................................................................................. 17................................................................................................................. 17
Registered Testing Pool .......................................................................... 17
Figure Skating ......................................................................................... 17
Speed Skating .......................................................................................... 18
Short Track Speed Skating ...................................................................... 18
Synchronized Skating .............................................................................. 18
Retirement and Return to Competition ................................................... 18
Skater Whereabouts Information ............................................................ 19................................................................................................................. 19
Waiver ..................................................................................................... 19

D-

THERAPEUTIC USE EXEMPTION ................................................. 19

E-

RIGHT TO A FAIR HEARING .......................................................... 21

2

INTRODUCTION
These ISU Anti-Doping Procedures take into account the ISU Anti-Doping Rules. Both the
ISU Anti-Doping Rules and ISU Anti-Doping Procedures have been compiled in accordancewith the World Anti-Doping Code and are effective immediately following approval by the
ISU Council and publication in this Communication.
References to the WADA Prohibited List are to the currently valid version of the List, as
published by WADA (www.wada-ama.org)(see ISU Anti-Doping Rules Articles 4.1 and 4.2).

A–

TESTING
A.1

Reference is made to Article 5.1 of the ISU Anti-Doping Rules, Authority to
Test, and Article 5.2, Responsibility for Testing.

A.2

The guidelines set out in the ISU Rules and Procedures apply to both In- andOut-of-Competition Testing.

A.3

Testing conducted on behalf of the ISU must comply with the ISU AntiDoping Rules and Procedures and with the International Standard for Testing(available at www.wada-ama.org). Such Testing may be conducted by the
National Anti-Doping Organization of the country where the Testing takes
place or by a specialist commercial Anti-Doping Agency appointed by the ISU.
The ISU remains the Testing Authority.

A.4

The Anti-Doping Testing procedure at any In-Competition Testing or Out-ofCompetition Testing may include Blood Sampling in addition to Urine
Sampling. The Doping Control Notification shall state whether the Skater isrequired to undergo Blood Sampling in addition to Urine Sampling. Blood
Sampling may be performed prior to, or after the Urine Sampling procedure.
A.4.1

All Samples provided by Skaters (urine and/or blood) immediately
become the property of the ISU.

A.5

During Out-of-Competition Urine Testing the following classes of Substances
will be tested:
Anabolic agents
Hormones and Related Substances
Beta-2 Agonists
Hormone Antagonists and Modulators
Diuretics and other Masking Agents
Stimulants
Narcotics
Prohibited methods

A.6

Additional Guidelines for Testing
A.6.1

All tests conducted at ISU events shall use the ISU Anti-Doping
Forms, which should be obtained from the ISU Secretariat. These
forms must also be used by any Anti-Doping Agency carrying out
ISU Out-of-Competition tests.

3A.6.2

These guidelines must be followed as closely as possible, however
deviation(s) from these guidelines shall not invalidate the finding ofa Prohibited Substance or Method, unless it was such as to cast
substantial doubt on the reliability of the finding. (See Article 3.2.2of the ISU Anti-Doping Rules)

A.6.3

Skaters selected for Out-of-Competition Testing will be notified by
the person(s) appointed by the Anti-Doping Agency approved by
the ISU to conduct the Testing. The appointed person(s) will
provide the Skater with photographic identification and a letterfrom the approved Anti-Doping Agency naming that person as a
Doping Control Officer authorized to conduct ISU Anti-Doping
Testing. The authorized person(s) will notify the Skater of thefollowing:
i)
ii)
iii)
iv)
v)
vi)
vii)
viii)
ix)

4

That the Skater is required to undergo Testing on the
ISU’s authority;
The type of Testing to be done, either blood or urine
or both;Any conditions that need to be adhered to prior to
sample collection;
Inquire if the Skater requires or requests an interpreter;
Of the requirement by the Skater to show
Identification;
Of the requirement for the Skater to sign the
notification part of the Anti-Doping Form;
Advise the Skater that they will be chaperoned until
the sample is collected;
Advise the Skater of possible consequences of failure
to comply;
Advise the Skater of location of the Anti-Doping
Station where the tests will be conducted.

A.6.4

For In-Competition Testing, the Chief Doping Control Officer(CDCO) is the person so designated by the organizing Member andapproved by a Medical Advisor from the ISU Medical Commission,
if present at the competition. If no Medical Advisor from the ISU
Medical Commission is present, the CDCO is the person designatedby the organizing Member. The CDCO may designate persons as
his/her representative to carry out the functions described in these
Procedures deemed suitable for performance by a representative.

A.6.5

Skaters selected for Testing shall be notified by the person(s)appointed by the Anti-Doping Agency approved by the ISU or by arepresentative of the CDCO using the ISU Anti-Doping Form or, if
approved by the ISU, may be notified with forms from the assigned
Anti-Doping Agency conducting the tests. Skaters mustacknowledge notification by signature and must appear withphotographic identification immediately. They must be
accompanied at all times after notification by a representative of the
CDCO of the same sex. For exceptions see Articles 6.6 and 6.7
below)

A.6.6

At Speed Skating World Cup competitions, the announcement of
the Skater(s) selected for Testing is made after the completion of
the second race of the selected Skater(s). However if the selected
Skater is only competing in one race on that day the announcement
will be made after the completion of his/her race.

A.6.7

Any Skater achieving a world record time in a World Cup
competition or ISU Championship must undergo Testing inaccordance with Rule 221, 4 f) and Rule 292, d) of the ISU Special
Regulations for Speed Skating and Short Track Speed Skating and
Article 5.7.4 of the ISU Anti-Doping Rules. If the existing world
record is broken more than once on the same day, in Competitions
at the same venue, the top three skaters achieving a world record
time must be selected for Anti-Doping Testing. They will beaccompanied, at all times, by a representative of the CDCO of thesame sex. They will report for Testing at that time according to
Article A.6.5 but if the Skater has been entered for a subsequent
race on the same day, he/she is not required to do so until
immediately after competing in this subsequent race of the day.
Should this be the case, they will be accompanied at all times
during the period between their races. If the Skater setting the world
record time chooses to complete their Testing after their first race
they would not be observed following completion of this Testing.
However they may be subject to random selection for Testing
following any subsequent races that day. If this Skater sets a world
record time in any subsequent race the same day, separate Testing
must be done after this race. In team disciplines, if a world record isachieved then a minimum of two skaters from the team shall betested.

A.6.8

Should the Skater fail to report to the Anti-Doping Station within
the time laid down in Article 6.5, this fact shall be recorded on the
Doping Control Form, signed by the official in charge of the Stationand delivered immediately through the CDCO to the ISU
Representative. If and when the Skater does appear at the Station
the sampling procedures shall still be carried out. The Skater is thenliable for sanctions according to Article 10 of the ISU Anti-Doping
Rules.

A.6.9

Upon arrival at the Anti-Doping Station, the Skater and one person
acceptable to the Skater shall be attended in the waiting room by arepresentative of the CDCO who shall confirm the identity of the
Skater, and shall note the time of arrival. Once the Skater hasreported to the Anti-Doping Station he / she must remain there
unless permission to leave is granted by the CDCO, and must becontinuously chaperoned by a representative of the CDCO until thesampling procedure is complete.

A.6.10

Personal belongings of the Skater and accompanying person may besearched for evidence of manipulation any time during the Testingprocedure.
5A.6.11No photographs, video or tape recordings may be taken inside theAnti-Doping Station during Testing. All communication devices
must be switched off during the sampling procedure.

A.6.12

In addition to the Skater and the one accompanying person, only thefollowing persons may be present in the Anti-Doping Station:-

6

The Chief Doping Control Officer;
The official in charge of the Anti-Doping Station;
The Doping Control Officer(s) (lady and/or man) incharge of taking and witnessing samples;
A medical technician, whose duties may include keeping
records;
A member of the ISU Medical Commission;
A representative of the ISU;
A Chaperone for each Skater;
An interpreter;
Administration support personnel as necessary.

A.6.13The Skater shall select a sealed sterile urine collector. He / she shallthen void a minimum of 90 ml of urine into the collector, witnessedby a Doping Control Officer of the same sex. Any clothing
preventing the direct observation of the urination shall be removed.

A.6.14

If the Skater refuses to comply, this shall be noted on the Doping
Control Form and the CDCO and the ISU Representative shall be
informed. The ISU Representative shall then decide on the further
steps to be taken. The Skater is then liable for sanctions according
to Article 10 of the ISU Anti-Doping Rules.

A.6.15

If a Skater is unable to provide a sufficient volume of urine, thesample shall be sealed with a tamper-proof seal and documented. Ifneeded, only sealed drinks should be provided for the Skater. Whenan adequate Sample volume is available from the Skater, theSample container seal may be opened and the sampling procedurecompleted.

A.6.16The Skater shall then select two tamper-proof bottles in a sealedbag, transfer an appropriate amount of the urine from the collecting
vessel into bottle A and bottle B and close the bottles to ensure that
there is no leak. The Doping Control Officer shall measure thespecific gravity (sg) of the urine left in the collecting vessel. If the
Sample does not meet the criteria of the sg of 1.010 or higher (using
sticks) or 1.005 (using a refractometer), then further Samples may
be required. If during Testing the Sample has evidence of blood,then a second Sample may be requested. Code numbers selected by
the Skater will be affixed to these bottles unless already on thebottles (Versapak or Bereg systems).

A.6.17The bottles shall then be sealed using a tamper-proof method,which cannot be violated without leaving obvious evidence of such

violation. All remaining urine shall be discarded immediately after
Sample collection procedures are completed.

A.7

A.6.18The bottle code numbers shall be entered on the Doping Control
Form.

A.6.19The Skater shall declare any medication and nutritional
supplements that he/she may have taken in the preceding three days
and the Doping Control Officer shall record this on the Doping
Control Form.

A.6.20The Skater and team official shall certify, by signing the form, thatthe details are correct and accurate and that there have been no
irregularities in the entire Sample taking and sealing procedure. The
CDCO and/or ISU Representative shall check and sign the Doping
Control Form. The Skater is given a copy. Laboratory copies of the
Doping Control Form for urine Samples shall be placed in a
separate envelope that shall be placed in the transport container
with the samples. The ISU copy is returned to the ISU Secretariat in
Lausanne. The remaining copy is retained on file by the member of
the ISU Medical Commission or ISU Representative or Referee.

A.6.21The sealed samples are placed in transmittal bags or containers andsent with the appropriate ISU Chain of Custody Forms. Eachtransport container shall then be sealed. The chain of custody shallbe maintained by signature until arrival at the laboratory.

A.6.22

The representative of the CDCO shall give the completed ISU
Doping Control Forms to the official in charge of the Anti-Doping
Station who shall keep them on file.

Analysis of Samples
A.7.1

The principles for the analysis of Samples are described in Article 6of the ISU Anti-Doping Rules and the International Standard forLaboratories (available at www.wada-ama.org).

A.7.2

Analysis of blood Samples may be carried out by the specialist
Doping Control Agency’s qualified expert using mobile Testing
units or at a recognised laboratory for the analysis of blood
Samples, as approved by WADA or the ISU.

A.7.3

If at any stage a question or issue arises on the Testing, analysis orinterpretation of results, the person responsible for analysis at thelaboratory may consult the ISU for guidance.

A.7.4

If at any stage a question or issue arises in relation to the Sample
and its analysis, the laboratory may conduct any further tests
necessary to clarify the issue raised and such tests may be relied
upon by the ISU when deciding whether a Sample has tested
positive for a Prohibited Substance or Method.

7

A.8

B-

Analysis of B Samples
A.8.1

In the event that the Member on behalf of the Skater requests theanalysis of the B Sample, as provided for in Article 7.1 of the ISU
Anti-Doping Rules, the costs associated with the analysis of the B
Sample (attendance by Skater or representative, etc.) are theresponsibility of the Member of the Skater who provided thepositive A Sample. If a representative of the ISU is appointed toattend the analysis of the B Sample, his/her travel expenses are paidby the ISU. A Skater may accept the A Sample analytical results by
waiving the requirement for B Sample analysis (Article 7.1.4 of the
ISU Anti-Doping Rules).

A.8.3

The analysis of the B Sample will be carried out according to
Article 7.15 of the ISU Anti-Doping Rules.

A.8.4

Until such time that the WADA Clearinghouse on ADAMS is fully
operational all results from all analyses will be sent without delay
ONLY to the ISU Director General and only in the case of apositive test to WADA. Once the WADA Clearinghouse on ADAMS
is fully operational all results from all analysis will be sent without
delay to both the ISU Director General and WADA.

IN-COMPETITION TESTING
B.1

As outlined in Article 5.1.2 of the ISU Anti-Doping Rules, Testing must be
carried out in accordance with the current ISU Anti-Doping Rules andProcedures at the following events: ISU Championships, World Cup
Competitions (Speed Skating and Short Track Speed Skating), Regional
Qualifying Events for Word Allround Speed Skating Championships, GrandPrix of Figure Skating and Final and Junior Grand Prix of Figure Skating and
Final, Open International Competitions, and all other events designated by the
ISU Council. These tests will be conducted under the supervision of a memberof the ISU Medical Commission, by a specialist Anti-Doping Testing Agency
appointed by the ISU or by the National Anti-Doping Organization of the hostcountry.
B.1.1

8

At ISU Championships, the ISU Junior Grand Prix of Figure
Skating and Final and ISU Grand Prix of Figure Skating and Final,
ISU World Team Trophy, Open International Competitions andother International Competitions where Testing is required
according to the ISU Anti-Doping Rules, it is the financial
responsibility of the organizing Member to provide Anti-Doping
equipment, facilities for analysis of samples, transportation ofsamples and to carry out Testing in accordance with the ISU Rules
and Procedures. Members failing to provide such services andequipment will be subject to disciplinary action according to
Articles 12.1 or 12.3 of the ISU Anti-Doping Rules.

B.2

B.3

B.1.2

All Anti-Doping expenses incurred by the Members organizing
World Cup and Qualifying Events for the ISU Championships
where no ISU support is provided, shall be reimbursed by the ISU.

B.1.3

The organising Member will be responsible for the logistical costsof the Doping Control Officers on site, including accommodationand meals

B.1.4

The member of the ISU Medical Commission or the approved AntiDoping Agency will make direct contact with the organizing
Member with regards to the logistical arrangements.

Supervision
B.2.1

A member of the ISU Medical Commission for the ISU WorldChampionships is appointed by the ISU Council and will be
responsible at the designated event for liaising with the Organising
Committee and the Anti-Doping Agency carrying out the Testingand includes the organisational aspects, and providing information
to the teams.

B.2.2

When no member of the ISU Medical Commission is present, a
representative of the ISU and/or of an Anti-Doping Agency
approved by the ISU or a physician approved by the Chairperson of
the ISU Medical Commission may carry out this role.

Facilities, Equipment and Personnel
B.3.1

Doping Control Station
The organizing Member shall provide a Doping Control Station thatis used solely as a Doping Control Station for the duration of the
Testing during the event. It is to be situated near to the Skater’schanging rooms and clearly marked, where Urine and Blood
Sampling can be undertaken. The Doping Control Station must
consist of a separate waiting area, an administrative working roomwith running water for a sink and separate toilet area. A lockablerefrigerator must be available on request for the administrative
room.

B.3.2

Sealed refreshments (mineral water, soft drinks, fruit juice etc.)
must be available in the waiting area. These drinks should only
contain water, minerals, sweeteners and carbohydrates. As per the
ISU Memorandum the Doping Control Station is also equippedwith a TV set. The Doping Control Station shall be adequately
equipped with facilities to allow the Doping Control Officer(s) andBlood Collection Official(s) to wash their hands and fulfil usual
medical standards.

B.3.3

Sample Collection Equipment
Sample collection equipment is provided by the organizing
Member, the National Anti-Doping Organization or the ISU
appointed Anti-Doping Agency responsible for carrying out the
tests.
9

It is the responsibility of the organizing Member to confirm whichof these organizations will provide the equipment for Testing. The
forms for the Testing must be obtained from the ISU Secretariat.

B.4

10

B.3.4

Support Personnel
The organizing Member shall appoint an Anti-Doping Testing
Coordinator who shall be responsible for the organization of
Testing, including contact with Doping Control Officers, the ISU
Medical Advisor and organization and supervision of Chaperones.
There must be a sufficient number of Chaperones, all of whommust be of legal age under the laws of the host country, toaccompany the Skaters after they have been selected to undergo
Testing. The Chaperones should of the same gender as the athlete
being tested and be able to communicate in English and if possible
other languages. The Chaperones should be able to recognise theSkaters on sight, otherwise the organizing Member shall provide an
additional person who can assist the Chaperone to identify a Skater.
It is helpful if the Chaperones can assist with translation during theTesting.

B.3.5

Accreditation of Doping Control Personnel
The organizing Member shall be responsible for ensuring that all
Doping Control Personnel, including WADA Independent
Observers, receive appropriate accreditation to enable them toaccess the necessary areas.

Selection and number of Skaters to be tested
B.4.1

The method of selecting Skaters and the total number to undergo
post-competition Testing must be decided before the beginning ofeach Competition and is outlined in Article 5.7 of the ISU AntiDoping Rules and Article B.4.3 and B.5 of the ISU Anti-Doping
Procedures.

B.4.2

Skaters selected at random will be drawn by the ISU Representativeor their delegate, in the presence of the member of the ISU Medical
Commission, when present, and/or the DCO from the assigned
Anti-Doping Agency, based on the ISU Anti-Doping Procedures.

B.4.3

The selection of the Skaters must be implemented by the final result
so that the Skaters or team officials have no warning before the endof the race/event in which the Skater is scheduled for Doping
Control.

B.4.4

Once a Skater has received notification for Testing, the Doping
Control Officer/Chaperone shall keep the Skater under observation
at all times. This applies to all activities such as a post-competition
warm down, which must be carried out under the observation of the
Doping Control Officer/Chaperone.

B.5

B.4.5

Any Skater participating in ISU Competitions may be subject toTesting. The notification may not infringe on the Competition itself
and shall respect the Competition program. Inappropriate timing ofa request to provide a Sample will not, however, invalidate therequest. Skaters may note any concerns on the Doping Control
Form.

B.4.6

In team disciplines, any Team member who is selected for Doping
Control testing must have participated in the team Competition
during the Event for which they are selected.

Skaters Selected for Post Competition Testing
B.5.1

The following guidelines for the different disciplines and events are
given to assist the Doping Control Officers, member of the ISU
Medical Commission and ISU Representative in determining the
Skaters to be tested and selected at random.

B.5.2

Figure Skating
B.5.2.1

In ISU Championships the following minimum
Testing will be carried out: the four best ranked
Skaters of the final result in the Singles (after the Free
Program), Pair Skating (after the Free Program) and
Ice Dance (after the Free Dance) shall be tested. One
Skater from the remainder of the Skaters shall beselected by random draw in Singles, Pair Skating and
Ice Dance. In Pair Skating and Ice Dance either theman or the lady, but not both, shall be tested and shallbe selected by random draw.

B.5.2.2

If there are qualifying rounds, Testing may be carriedout at this time. In this case at least one Skater will berandomly selected from each group, A and B, men andladies. Skaters may be tested more than once during
the Competition.

B.5.2.3

Additional Skaters may be selected for Testing by the
ISU Representative or, at his/her discretion, by the
CDCO. Such selection may be based upon a randomdraw determined by the placement in a previous
portion of that Competition, or by the final result.

B.5.2.4

In the ISU Junior Grand Prix of Figure Skating and
Final, the ISU Grand Prix of Figure Skating, Final,
Figure Skating Olympic Qualifying Competitions, andISU World Team Trophy, Testing will be carried out on
the best Skater of the final result in Singles (after the
final free program), Pair Skating (after the final freeprogram) and Ice Dance (after the final free dance). One
Skater from the remainder of the Skaters shall beselected by random draw in Singles, Pair Skating and
Ice Dance.
11

In Pair Skating and Ice Dance either the man or the lady,
but not both, shall be tested and shall be selected byrandom draw. Testing will be carried out according to
the current ISU Anti-Doping Rules.

B.5.3.

B.5.2.5

In Open International Competitions or New
Method/System Competitions sanctioned by the ISU,
Testing is mandatory and all Skaters competing at
International
Open
Competitions
or
New
Method/System Competitions, including the ineligible
Skaters, may be tested. In addition to the winner, aminimum of one Skater per discipline shall be selectedby random draw to be tested.

B.5.2.6

Prior to Open International Competitions, all Skaters
entered for such Competitions must accept in writing
to submit to Testing that will be conducted under thecontrol of the organizing Member and in consultation
with the ISU Medical Commission. Skaters who refuse
to accept this procedure will not be allowed to skate.
In the case of refusal to give the required Sample after
the Competition and in the case of positive results,
sanctions as per the ISU Rules will apply for eligible
Skaters.
For ineligible Skaters the ISU Council will take thenecessary decision, which may consist of preventing
the ineligible Skater involved from being invited toOpen International Competitions/ New Method/
System Competitions for a certain period of time andwithholding the payment of prize money and otherbenefits. In this respect, the organizing Member will
pay the Skaters’ benefits only after the Competition
and upon receipt of Testing results.

Synchronized Skating
B.5.3.1

12

For the World Synchronized Skating Championships
and other Events designated by the ISU, two Skaters
randomly selected from the 1st, 2nd and 3rd placed
teams and two Skaters from one randomly selected
team shall be tested. Both the junior and senior teams
will be tested. At the time of the draw two alternative
numbers from all teams to be tested will be drawn toensure that the Skaters tested have skated in thecompetition.

B.5.4

Speed Skating
B.5.4.1

For Two Day Championships
Minimum Skaters to attend the Testing:• First day - For both ladies and men the best
ranked and one other Skater, randomly drawn, in
the long distance shall be tested.
• Second day – For both ladies and men the three
best ranked of the final result and one other Skaterrandomly drawn shall be tested.

B.5.4.2

For Three Day Senior Championships
Minimum Skaters to attend Testing:• First day – For both ladies and men the overallbest ranked and one other Skater, randomly drawn,
shall be tested.
• Second day – For both ladies and men the overallbest ranked Skater and one other, randomly drawn,
shall be tested.
• Third day – For both ladies and men the three
best-ranked Skaters of the final result and one
other Skater, randomly drawn, shall be tested. In athree day Championship where the program for theindividual ladies and men is completed in two days
then the 2-day selection procedure in Article
B.5.4.1 will apply.

B.5.4.3

Team Pursuit Events
In team pursuit events one Skater from the winningteam and one Skater from a randomly selected teamshall be tested. The Skater from each team will berandomly selected from the team list.

B.5.4.4

For World Single Distances Speed SkatingChampionships
Minimum Skaters to attend Testing: For both ladies
and men the two best ranked and one randomly
selected Skater in each distance shall be tested. The
same Skater will be tested only once on the same daywith the exception of necessary Testing for the settingof a world record. If the randomly selected Skater iscompeting in two different distance races on the same
day the conditions regarding random selections
referred to in Article A.6.6 will apply. If the winner ofa race is competing in a second race on the same day
he/she will be treated according to Article A.6.7,
similar to world record holders.

13

14

B.5.4.5

For Senior World Cup Competitions
Minimum Skaters to attend Testing: On each day ofcompetition for both ladies and men, for each distance
two randomly selected Skaters shall be tested. In
competitions where there are Divisions A and B, one
randomly selected Skater from Division A and one
randomly selected Skater from Division B will betested. If the same distance (eg: 500, 1000, or 1500 m)
is skated twice during the same event but on different
days, each day one randomly selected Skater from
Division A and, if applicable, one randomly selected
Skater from Division B will be tested. The same
Skater selected on this random basis will be tested
only once on the same day. However if this same
Skater subsequently sets a world record he/she will be
notified of further Testing based on the world record
time and not on random selection, in accordance with
Article A.6.7. In this case an additional randomly
selected Skater will be tested.
If a 100 meters distance is raced in a World Cup
Competition only one randomly selected Skater shallbe tested.

B.5.4.6

For Junior World Cup Competitions
Minimum Skaters to attend Testing: On each day ofcompetition for both ladies and men, for each distance
two randomly selected Skaters shall be tested. In
competitions where there are Divisions A and B, one
randomly selected Skater from Division A and one
randomly selected Skater from Division B will betested. If the same distance (eg: 500, 1000, or 1500 m)
is skated twice during the same event but on different
days, each day one randomly selected Skater from
Division A and, if applicable, one randomly selected
Skater from Division B will be tested. The same
Skater selected on this random basis will be tested
only once on the same day. However if this same
Skater subsequently sets a world record he/she will be
notified of further Testing based on the world record
time and not on random selection, in accordance with
Article A.6.7. In this case an additional randomly
selected Skater will be tested.
If a 100 meters distance is raced in a Junior World
Cup competition only one randomly selected Skatershall be tested. If a team pursuit is raced in a JuniorWorld Cup competition, then Article B.5.4.3 applies.

B. 5.4.7

B.5.5

For World Junior Championships
Minimum Skaters to attend Testing:• First Day – For both ladies and men one randomly
selected Skater in each distance event shall betested, except for the 1500m ladies where the best
ranked and one randomly selected Skater shall betested.
• Second Day – For both ladies and men the best
ranked and one randomly selected Skater in eachdistance event shall be tested. For the allroundcompetition the best ranked skater in the allroundcompetition shall be tested. If the first ranked
skater has already been selected for testing thatday, the second ranked skater shall be tested
instead.
• Third Day – For both ladies and men the winnerand one randomly selected Skater in each distanceevent shall be tested. In the team pursuit event one
randomly selected Skater from the winning teamshall be tested.
The same Skater will be tested only once on the same
day with the exception of necessary testing for thesetting of a world record. If a randomly selected
Skater is competing in two different distance races on
the same day the conditions regarding random
selections referred to in Article A.6.6 will apply. If thefirst ranked skater of a race is competing in a second
race on the same day he/she will be treated according
to Article A.6.7, similar to world record holders.

Short Track Speed Skating
B.5.5.1

For the World Short Track, Junior World Short Trackand European Short Track Speed SkatingChampionships
Minimum Skaters to attend Testing:• For both ladies and men, the first and one
randomly selected Skater, from the ranking list ineach of the distances 1500, 1000, 500 meters shallbe tested. On the final day after the overall
ranking, for both ladies and men, the 1st, 2nd and
one randomly selected Skater, shall be tested.
• In the relay competition, on the final day, for bothladies and men, one Skater who participated in therelay competition, from a team selected at random,
shall be tested. This Skater from the relay teamwill be selected at random from the team list
provided by the Competitors Steward. The same
Skater will be tested only once on the same day.

15

•

16

If the winner of a distance is competing in asecond distance on the same day he/she will betreated according to Article A.6.7, similar to world
record holders.

B.5.5.2

For World Short Track Speed Skating TeamChampionships
Minimum Skaters to attend Testing:• On the first day, in each of the two qualifying
brackets for both ladies and men, one Skater fromthe first ranked team, and one Skater from thefourth ranked team shall be tested. In therepechage for ladies and men, one Skater from thefirst ranked team and one from a randomly
selected team will be tested. A random Skater fromeach of the teams will be selected from the teamlists provided by the Competitors Steward.
• On the final day for both ladies and men, one
Skater from the first ranked team in the B-final andone Skater from the first and second ranked teamsin the A-final will be tested. A random Skaterfrom each of these teams will be selected from theteam lists provided by the Competitors Steward.

B.5.5.3

For Short Track Speed Skating World Cup
Competitions
Minimum Skaters to attend Testing:• For each distance classification (500 m, 1000 m,
1500 m), for both ladies and men, the first and one
Skater selected randomly shall be tested.
• For the relay competition, after the finalclassification, for both ladies and men, one Skaterin the relay competition from a randomly selected
team in the top 4 ranked teams, shall be tested.
This Skater from the relay team will be selected at
random from the team list provided by theCompetitors Steward. The same Skater will betested only once on the same day.
If the winner of a distance is competing in asecond distance on the same day he/she will betreated according to Article A.6.7, similar to world
record holders.

B.5.5.4

For Short Track Speed Skating Olympic Qualifying
Competitions
The minimum Skaters to attend Testing:• For both ladies and men, the first ranked plus one
Skater from 1500, 1000 and 500 meters selectedby random draw shall be tested.

•

B.6

C-

In the relay competition, for both ladies and men,
two Skaters in the relay competition from two
different teams, selected at random from the 8ranked teams, shall be tested.
These Skaters from the relay teams will beselected at random from the team lists provided by
the Competitors Steward. The same Skaters will betested only once on the same day.
If the winner of a distance is competing in asecond distance on the same day he/she will betreated according to Article A.6.7, similar to world
record holders.

Notification and attendance at the Doping Control Station
B.6.1

Details of the notification procedure and attendance at the Doping
Control Station are described in Article A.5.4, A.5.5 and A.5.6.

B.6.2

The persons authorised to be present in the Doping Control Station
are described in Article A.5.12.

B.6.3

Photographs or films may not be taken in the Doping Control
Station at any time during Doping Control. It is recommended thata representative of the CDCO be positioned outside the Doping
Control Station to monitor the flow of people in and out and to keep
unauthorised persons from entering the Station.

OUT-OF-COMPETITION TESTING
C.1

Notification of Out-of-Competition Testing is outlined in Article A.6.3 of the
ISU Anti-Doping Procedures.

C.2

Substances and methods tested in Out-of-Competition are listed in Article A.5of the ISU Anti-Doping Procedures.

C.3

Registered Testing Pool
The following criteria determine the Skaters listed in the ISU Registered
Testing Pool:
C.3.1

Figure Skating
Skaters ranked in the top 10 of the previous season’s World Figure
Skating Championships and Junior Skaters ranked in the top five of
the previous season’s World Junior Figure Skating Championshipsof each discipline of Figure Skating (singles Men and Ladies, Pairs
and Ice Dance) shall be included in the ISU Registered Testing
Pool. Additional Skaters may be added by the ISU based on Testing
results and performance. A Skater will only be excluded following
official announcement of retirement to the ISU by his/her Member.
Additionally any Skater who is not ranked in the top 10 of their
specific discipline and may be entered for a major Event (WorldChampionships, Olympic Winter Games) may also be included in
the ISU Registered Testing Pool.
17

18

C.3.2

Speed Skating
For both ladies and men the participants in the previous season’sWorld Allround Championships, World Sprint Championships, the
5 best ranked of each distance in the World Single DistancesChampionships, and the 3 best ranked Skaters from the previous
season’s World Junior Championships shall be included in the ISU
Registered Testing Pool. Additional Skaters may be added by the
ISU based on Testing results (urine and/or blood), andperformance. A Skater will only be excluded following official
announcement of retirement to the ISU by his/her Member.
Additionally any Skater who is not ranked in this list but may beentered for a major Event (World Championships, Olympic WinterGames) may also be included in the ISU Registered Testing Pool.

C.3.3

Short Track Speed Skating
For both ladies and men the 30 best ranked individual Skaters andthe Skaters in the 5 best ranked Relay Teams from the previous
season’s World Short Track Speed Skating Championships and the
5 best ranked Skaters from the previous season’s World Short
Track Junior Championships shall be included in the ISU
Registered Testing Pool. Additional Skaters may be added by the
ISU based on Testing results (urine and/or blood), andperformance. A Skater will only be excluded following official
announcement of retirement to ISU by his/her Member.
Additionally any Skater who is not on the above list but may beentered for a major Event (World Championships, Olympic WinterGames) may also be included in the ISU Registered Testing Pool.

C.3.4

Synchronized Skating
Skaters ranked in the top two teams from the previous WorldChampionships shall be included in the ISU Registered Testing
Pool. Additional Skaters may be added by the ISU based on AntiDoping test results and performance. Any Skater who moves into
the top two teams during the season should be included in the ISU
Registered Testing Pool. A Skater who drops out of the top twoteams will only be excluded following official announcement of
retirement to the ISU by his/her Member.

C.3.5

Retirement and Return to Competition
A Skater ranked within the above criteria of the respective
discipline at the time of retirement, who decides to return tocompetition and is re-registered with the ISU by his/her Member,will be included in the ISU Registered Testing Pool for the current
season after which time the above criteria will apply.

C.4

D-

Skater Whereabouts Information
The requirement for up-to-date whereabouts information is defined in Article
5.5 of the ISU Anti-Doping Rules. Any correspondence with regards towhereabouts information will be sent to the Member of the Skater.
C.4.1

During June of each year, each Member with Skaters who qualify
for inclusion in the ISU Registered Testing Pool will be sent a listof such Skaters who must submit whereabouts on a quarterly basis.
The deadlines for submission of whereabouts information are July
1, October 1, January 1 and April 1 of each year. Whereabouts
informationmust
besubmitted
on
ADAMS
at
https//www.adams.wada-ama.org.

C.4.2

The requirement for the provision of whereabouts information for
new Skaters who reach the criteria for inclusion in the ISU
Registered Testing Pool during the course of the season will be sent
to the Member of the Skater after the criteria have been reached.

C.4.3

Similarly, the requirement for the provision of whereabouts
information for Skaters subject to Reinstatement Testing as definedin Article 10.10 of the ISU Anti-Doping Rules will be sent to theMember of the Skater.

C.4.4

Notification of Skaters for Out-of-Competition Testing is defined in
Article A.6.3 of the ISU Anti-Doping Procedures.

C.5

Costs for Out-of-Competition Testing organised and carried out by the World
Anti-Doping Agency (WADA) or the ISU are covered by WADA and/or the
ISU.

C.6

Waiver
The nature of Out-of-Competition Anti-Doping Testing makes it inevitablethat except in extraordinary circumstances no advance notice is given to the
Skater. Every effort will be made by the persons appointed by the Anti-Doping
Agency approved by the ISU to conduct the Testing to collect the Samples
speedily and efficiently with the minimum of interruption to the Skater’s
training plans and/or to his/her social or work schedule. If there is aninterruption, however, then no Skater may take any action to gain
compensation for any inconvenience caused, or loss of earnings.

THERAPEUTIC USE EXEMPTIONS (TUE)

If an Athlete provides the required medical justification for a Therapeutic Use Exemption(TUE) to the reasonable satisfaction of the ISU TUE Committee, in line with the International
Standard for TUEs (available at www.wada-ama.org), a TUE may be granted to an Athlete
permitting the Use of a Prohibited Substance or a Prohibited Method contained in theProhibited List.

19

D.1

Application Process
D.1.1

A TUE will only be considered following receipt of a completed
application form, including all relevant supporting documents (seeAppendix 1 for TUE application form). Applications should usually
be submitted no less than thirty (30) days before the approval isneeded. All applications will be dealt with in accordance with theprinciples of strict medical confidentiality.

D.1.2

A Skater must not apply to more than one Anti-Doping
Organization for a TUE. The application must identify the Skater’s
discipline where appropriate.

D.1.3

The application must list any previous and/or current requests for
permission to use an otherwise Prohibited Substance or Prohibited
Method, the Anti-Doping Organization to which that request was
made, and the decision of that Organization.

D.1.4 The application must include a comprehensive medical history and the results of all
examinations, laboratory investigations and imaging studies relevant to the application.

20

D.1.5

Any additional relevant investigations, examinations or imaging
studies requested by the Therapeutic Use Exemption Committee(TUEC) of the ISU will be undertaken at the expense of the Skateror the Member of which the Skater is a member.

D.1.6

The application must include a statement by an appropriately
qualified physician attesting to the necessity of the otherwise
Prohibited Substance or Prohibited Method in the treatment of the
Skater and describing why an alternative, permitted medication
cannot, or could not, be used in the treatment of this condition.

D.1.7

The dose, frequency, route and duration of administration of theotherwise Prohibited Substance or Prohibited Method in question
must be specified. In case of change, a new application shall be
submitted.

D.1.8

Decisions of the TUEC will be conveyed in writing to the Skater by
the ISU. The Skater and WADA will be promptly provided with anapproval certificate which includes information about the durationof the exemption and any conditions associated with the TUE.

D.1.9

An application for a TUE will not be considered for retroactive
approval except in cases where:• emergency treatment or treatment of an acute medical
condition was necessary• due to exceptional circumstances, there was insufficient timeor opportunity for an applicant to submit, or the TUEC toreceive, an application prior to Doping Control.

D.3

A review by the TUEC may be initiated at any time during the duration of the
TUE.
D.3.1

A TUE may be cancelled by the TUEC at any time. The Skater,
his/her Member and WADA shall be notified immediately.

D.3.2

The cancellation shall take effectnotification of the decision to the Skater.

immediately

following

D.4 Declaration of Use Process
The List of Prohibited Substances identifies certain substances andmethods that are not prohibited but for which a Skater is required to filea declaration of use. A skater should satisfy this requirement by
declaring the Use on a Doping Control Form and, when available, by
filing a declaration of use through ADAMS. These include thefollowing:
Salbutamol and Salmeterol by inhaled route; Glucocorticosteriods usedby inhaled and non-systemic routes, namely intraarticular, periarticular,
peritendinous, epidural, intrathecal and intradermal injection.

E-

RIGHT TO A FAIR HEARING
E.1

Article 8 of the ISU Anti-Doping Rules sets out the requirements for a hearing
process.

E.2

If, following the Results Management process described in the ISU AntiDoping Rules, and after conferring with relevant experts to the extent deemed
appropriate, it appears likely in the joint judgement of the Chairperson of theMedical Commission and the Director General that a violation of the ISU AntiDoping Rules has occurred, the case shall be reported to the ISU President who
shall refer the same to the ISU Disciplinary Commission (hereafter the DC) as
provided for in Article 8.1 of the ISU Anti-Doping Rules.
The following procedures give additional detail to Article 8.1 of the ISU AntiDoping Rules and supersede any conflicting provisions in the Disciplinary
Commission Rules of Procedure.

E.3

The Skater or Other Person alleged to have violated the ISU Anti-Doping
Rules has the right to a hearing and may present their case either in writing orin person to the ISU DC.

E.4

The request for an oral hearing of the Skater or Other Person must be made inwriting to the ISU DC within 21 days of the notification to the Skater or Other
Person and the Member of the Skater or Other Person from the ISU DC that aproceeding concerning the alleged Anti-Doping Rule violation will be
conducted.

21

E.5

An oral hearing shall in principle take place within 3 months following thecompletion of the results management process.
If a Provisional Suspension is imposed on the Skater under Article 7.6.1 or7.6.2 of the ISU Anti-Doping Rules, the ISU shall promptly notify the Skaterand their Member of:a) The Provisional Suspension imposed;b) The Skater’s right to a Provisional Hearing, to determine whether theProvisional Suspension shall be maintained until the full consideration of
the case by the ISU DC;c) The Skater’s right to accept the Provisional Suspension and waive the rightto a Provisional Hearing.
d) The right of the Skater to request an expedited full Hearing by the ISU DC.
If the Skater requests a Provisional Hearing, that Hearing shall take place assoon as reasonably possible and in accordance with Article 8.1 of the ISU
Anti-Doping Rules. The Provisional Hearing shall consider only whether theProvisional Suspension shall be maintained until the full consideration of thecase by the ISU DC takes place. The decision of the ISU DC in a Provisional
Hearing is final and may not be appealed.

22

E.6

The ISU DC shall determine the nature and circumstances of any breach of the
ISU Anti-Doping Rules that may have been committed. It shall allow the
Skater or Other Person an opportunity to give an explanation orally at ahearing, by telephone, videoconference, or in writing concerning thecircumstances and the facts in relation to the alleged violation of the ISU AntiDoping Rules.

E.7

If no request for a hearing of the Skater or Other Person alleged to haveviolated the ISU Anti-Doping Rules is made within 21 days, the ISU DC will
adjudicate the case based on the available facts of the alleged Anti-Doping
Rule violation unless the ISU DC decides at its sole discretion to hold ahearing.

E.8

In accordance with Article 8.1.7 of the ISU Anti-Doping Rules, the Skater orOther Person may at any stage acknowledge in writing the Anti-Doping
violation and accept the consequences as set forth in Articles 9 and 10 of the
ISU Anti-Doping Rules, details of which will be expressed by the ISU DC.

E.9

The ISU DC, through the ISU Secretariat will advise the Skater or Other
Person and the Skater or Other Person’s Member of the time and place of thehearing..

E.10

The Skater or Other Person may submit evidence for the defence of the casethat does not require the use of disproportionate means. The ISU DC shallmake a decision in this regard.

E.11

The ISU DC may seek the opinion of experts.

E.12

After completion of the hearing, the ISU DC shall compile a timely, written,
reasoned decision.

E.13

Appeals
Decisions made under the ISU Anti-Doping Rules may be appealed as set forthin Article 13.2 through Article 13.5 of the ISU Anti-Doping Rules. A decisionof the ISU DC shall remain in effect as a provisional order while under appeal,
unless the appellate body orders otherwise.

E.14

Public Disclosure
A public disclosure of any decision of the DC regarding an Anti-Doping Ruleviolation will be made in an ISU Communication as provided for in the ISU
Constitution, Article 27, paragraph 2 and Article 14.4 of the ISU Anti-Doping
Rules. Prior to such an announcement, all parties are obliged to treat the matterin strict confidence.

Milan,

Ottavio Cinquanta, President
December 29, 2009

Lausanne,

Fredi Schmid, Director General23Appendix 1

Therapeutic Use Exemptions
Application Form
I apply for approval from the International Skating Union for the therapeutic use of a prohibited
substance on the WADA List of Prohibited Substances and Prohibited Methods.
Please complete all sections in BLOCK CAPITALS

1. Athlete Information

Surname: ................................................

Given Names: .....................................................

Female  Male  (tick appropriate box)

Date of Birth (d/m/y): ........................................

Address: . .....................................................................................................................................
City: ...........................................
Tel:

Country: ................... ................... Postcode: ........

........................................................................... Email: . ..............................................

Sport: ........................................................ Discipline: ................................................................
ISU Member: ..............................................................................................................................
Please mark the appropriate box:
 I am part of the ISU Registered Testing Pool
 I am part of my National Anti-Doping Organization Testing Pool
 I am participating in an ISU international event for which a TUE granted pursuant to the ISU’s
Anti-Doping Rules is required – Name of the competition: ......................................................................
 None of the above

2. Medical information
Diagnosis with sufficient medical information (see note 1):……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………

If a permitted medication can be used to treat the medical condition, provide clinicaljustification for the requested use of the prohibited medication:……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………

24

STRICTLY CONFIDENTIAL
3. Medication details
Prohibited Substance(s):Generic Name

Dose

Route

Frequency

1.

2.

3.

Anticipated duration of treatment(please tick appropriate box)

once only emergency or duration (week/month):  ……………………

Have you submitted any previous TUE application?  yes

 no

For which substance? ................................................................................................................................
To whom? …………………………………………
Decision:

Approved When? .............................................................

Not approved 

4. Medical doctor’s declaration
I, ………………………………………………………. Certify that I am a licensed Medical Doctor
treating the applicant athlete and I further certify that the above-mentioned treatment is medicallyappropriate and that the use of alternative medication not on the prohibited list would be unsatisfactory
for this condition.
Name ...........................................................................................................................................................
Medical speciality: ......................................................................................................................................
Address: .......................................................................................................................................................
Tel.: .............................................................................. Fax: ....................................................................
Email: ........................................................................... ............................................................................
Signature of Medical Doctor: ……………………………………………..Date: ………………….

25

STRICTLY CONFIDENTIAL

5. Athlete’s declaration
I, ………………………………………… certify that the information under 1. is accurate and that
I am requesting approval to use a Substance or Method from the WADA Prohibited List. I
authorize the release of personal medical information to the Anti-Doping Organization (ADO) as
well as to WADA staff and to the WADA TUEC (Therapeutic Use Exemption Committee) and toother ADOs under the provisions of the Code.
I understand that my information will only be used for evaluating my TUE request and in thecontext of possible anti-doping violation investigations and procedures. I understand that if I everwish to i) obtain more information about the use of my information; ii) exercise my right of accessand correction; or iii) revoke the right of these organizations to obtain my health information I must
notify my medical practitioner and my ADO in writing of that fact. I understand and agree that it
may be necessary for TUE-related information submitted prior to revoking my consent to beretained for the sole purpose of establishing a possible anti-doping rule violation, where this isrequired by the Code.
I understand that if I believe my personal information is not used in conformity with this consent
and the International Standard for the Protection of Privacy and Personal Information, I can file acomplaint to WADA or CAS.
Athlete’s signature: ..............................................................

Date: ....................................

Parent’s/Guardian’s signature: ..........................................

Date: ...................................

(if the athlete is a minor or has a disability preventing him/her to sign this form, a parent or
guardian shall sign together with or on behalf of the athlete)
6. Notes
Note
1

Diagnosis
Evidence confirming the diagnosis must be attached and forwarded with this application. The
medical evidence should include a comprehensive medical history and the results of all
relevant examinations, laboratory investigations and imaging studies. Copies of the originalreports or letters should be included when possible. Evidence should be as objective as
possible in the clinical circumstances and in the case of non-demonstrable conditions
independent supporting medical opinion will assist this application.

Incomplete Applications will be returned and will need to be resubmitted.
Please submit the completed form to the ISU and keep a copy for your records.

26

STRICTLY CONFIDENTIAL

TUEC Decision (for office use only)
Date Received:
Application Complete:  yes  no
Office Notes: ....... ...........................................................................................................................................
..........................................................................................................................................................................
..........................................................................................................................................................................
..........................................................................................................................................................................
Name of TUEC Representative(s): ......... ....................................................................................................
Signature(s): . ................................................................................................................................................
........................ ................................................................................................................................................
Date:... ...........................................

27